CEREGENE

Ceregene is a private, San Diego-based biotechnology company focused on the treatment of major neurodegenerative disorders using the delivery of nervous system growth factors. Their clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor, which is about to enter Phase 2 studies for the treatment of Alzheimer's disease, and CERE-120, which recently completed a Phase 2 trial in Parkinson's disease and is currently being evaluated for future development. CERE-135 and CERE-140 are in preclinical development for amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and ocular diseases, respectively.

#SimilarOrganizations #People #Financial #Website #More

CEREGENE

Social Links:

Facebook

Industry:

Biotechnology Health Diagnostics Pharmaceutical

Founded:

2000-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.ceregene.com

Total Employee:

51+

Status:

Active

Contact:

(858)458-8800

Email Addresses:

[email protected]

Total Funding:

71.5 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Sitelinks Search Box Organization Schema